Get the Stockscreener App
22.73
1.93%
0.43
Pre-market:
22.98
0.25
+1.10%
Innoviva Inc stock is traded at $22.73, with a volume of 630.84K.
It is up +1.93% in the last 24 hours and up +5.82% over the past month.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
See More
Previous Close:
$22.30
Open:
$22.36
24h Volume:
630.84K
Relative Volume:
0.79
Market Cap:
$1.70B
Revenue:
$384.03M
Net Income/Loss:
$38.65M
P/E Ratio:
73.32
EPS:
0.31
Net Cash Flow:
$196.35M
1W Performance:
-6.23%
1M Performance:
+5.82%
6M Performance:
+8.65%
1Y Performance:
+29.37%
1-Day Range:
$22.10
$22.93
1-Week Range:
$22.10
$25.14
52-Week Range:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
22.73 | 1.67B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Initiated | BTIG Research | Buy |
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Assessing Innoviva (INVA) Valuation After Strong Earnings Growth And Portfolio Expansion - simplywall.st
Vanguard Group Inc. Sells 81,916 Shares of Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. $INVA Shares Bought by Royce & Associates LP - MarketBeat
CVRX,INVA Dividends - Finviz
Innoviva, Inc. (INVA) Stock Analysis: With A 45% Potential Upside, Is It Time To Buy? - DirectorsTalk Interviews
Profit Recap: Will Innoviva Inc benefit from current market trendsTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
INNOVIVA INC (NASDAQ:INVA) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template - ChartMill
Innoviva’s 2025 Earnings and NUZOLVENCE Launch Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
INVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
INVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31Here's Why - Bitget
Is It Time To Reassess Innoviva (INVA) After Its Strong Multi Year Share Price Run - Yahoo Finance
Innoviva (INVA) One Off Gain Driven 65.9% Margin Challenges Bullish Earnings Narratives - Sahm
Innoviva CEO Details 3-Part Growth Plan, $125M Buyback, and 2026 Catalysts at Oppenheimer Conference - MarketBeat
Innoviva, Inc. (INVA): A Bull Case Theory - Yahoo Finance
Wall Street Recap: Whats the profit margin of Knowles CorporationMarket Risk Analysis & High Conviction Buy Zone Alerts - baoquankhu1.vn
Innoviva, Inc. Hits New 52-Week High at $24.25, Showcasing Strong Growth - Markets Mojo
Cantor Fitzgerald Maintains Overweight on INVA Innoviva, Inc Feb 26 2026 - Meyka
Innoviva, Inc. (NASDAQ:INVA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Innoviva earnings beat by $1.37, revenue topped estimates - Investing.com Canada
Innoviva's (INVA) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Innoviva’s NUZOLVENCE Approval And Buyback Reframe Growth And Valuation Story - Sahm
Innoviva stock hits 52-week high at 24.02 USD By Investing.com - Investing.com Australia
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results, Beats Estimates By $1.60 EPS - MarketBeat
Innoviva Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Innoviva: Fourth Quarter Earnings Overview - Bitget
Earnings Flash (INVA) Innoviva, Inc. Reports Q4 Revenue $114.6M, vs. FactSet Est of $102.6M - marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress - Business Wire
Innoviva stock hits 52-week high at 24.02 USD - Investing.com
Innoviva (NASDAQ:INVA) Reaches New 52-Week HighHere's What Happened - MarketBeat
Earnings Beat: Should I invest in Innoviva Inc before earningsJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
(INVA) Risk Channels and Responsive Allocation - Stock Traders Daily
Innoviva: Q4 Earnings Snapshot - theheraldreview.com
Innoviva, Inc. (INVA) Stock Analysis: Exploring A 40.97% Potential Upside For Investors - DirectorsTalk Interviews
Innoviva (INVA) CFO has 1,244 shares withheld for equity tax obligations - Stock Titan
Innoviva (INVA) CEO has shares withheld to cover equity vesting taxes - Stock Titan
First Week of April 17th Options Trading For Innoviva (INVA) - Nasdaq
Public Sector Pension Investment Board Increases Holdings in Innoviva, Inc. $INVA - MarketBeat
MSN Money - MSN
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - BioSpace
BTIG Research Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Upgraded to "Strong-Buy" at BTIG Research - MarketBeat
Innoviva stock gains BTIG coverage with buy rating on royalty windfall - Investing.com Nigeria
Innoviva, Inc. (INVA) Stock Analysis: Potential 43% Upside Captivates Investors - DirectorsTalk Interviews
BTIG Initiates Innoviva at Buy With $35 Price Target - marketscreener.com
BTIG Initiates Coverage on Innoviva (INVA) with a 'Buy' Rating | - GuruFocus
BTIG Initiates Coverage of Innoviva (INVA) with Buy Recommendation - Nasdaq
Innoviva (INVA) price target decreased by 12.36% to 32.90 - MSN
Will Innoviva Inc. outperform tech stocksJuly 2025 Action & Verified Technical Trade Signals - mfd.ru
(INVA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Earnings Miss: What is the next catalyst for Innoviva Inc.2025 Investor Takeaways & Technical Pattern Alert System - mfd.ru
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):